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Abstract
Asthma is a heterogeneous disease, and airway inflammation has an important 
role in its pathogenesis. Some nutritional factors can influence the process of 
asthma. It is reported that saffron has anti-inflammatory, antioxidant, and muscle 
relaxant effects, and some animal and human studies showed that saffron and its 
active components (safranal and crocin) improved the asthma biomarkers and clini-
cal symptoms. Some other nutritional factors also affect asthma; for example, mag-
nesium can relax the muscles and thus has bronchodilatory effects. Curcumin is the 
major active component of turmeric which has a potent antioxidant, anti-inflam-
matory, and anti-allergic effects. Because some researchers suggested that intestinal 
microbial flora has an important role in allergy, probiotics can be a complementary 
supplement for asthmatic patients. Generally nutritional factors could be advised 
for asthmatic patients with the goal of reducing the needs for chemical drugs.
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1. Introduction
Asthma is usually associated with chronic inflammation of airway [1]. In 
asthmatic patients, bronchial hyper-responsiveness, airway inflammation, and 
also airway remodeling are the prominent features. This chronic respiratory disease 
affects over 300 million people worldwide, and it is estimated that it will probably 
become more than 400 million by 2020 [2]. The WHO has estimated that 15 million 
disability-adjusted life-years are lost annually due to asthma [3]. Asthma disease 
imposes many economic and social burdens [4].
Nutritional advices have an important role in the improvement of lung function 
of asthmatic patients.
2. Saffron and asthma
Saffron (Crocus sativus L.) has antioxidant [5], anti-inflammatory [6], and 
muscle relaxant effects [7] and so has beneficial effects on asthma. Results of our 
clinical trial showed that saffron supplementation (100 mg of dried saffron stigma 
in capsules) for 8 weeks in mild and moderate allergic asthmatic patients improved 
the lung function by increasing the forced expiratory volume in 1 second (FEV1), 
forced vital capacity (FVC), FEV1/FVC ratio, and forced expiratory flow (FEF) 
25-75 and decreased some inflammatory factors (anti-HSP 70 and hs-CRP) in 
comparison to placebo [8]. In this trial the clinical symptoms of patients (including 
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frequency of the shortness of breath during day- and nighttime, use of salbutamol 
spray, waking up due to asthma symptoms, and activity limitation) improved after 
saffron supplementation [9].
Some animal studies also investigated the effects of saffron on asthma. 
Active constituents of saffron (safranal and crocin) have antioxidant and anti-
inflammatory effects and so have beneficial effects on asthma. This is reported that 
saffron supplementation in animals with allergic asthma decreased eosinophils, 
basophils, and total white blood cells, and some of these effects were found to be 
equal to dexamethasone [10]. Saffron supplementation in guinea pig with allergic 
asthma decreased the serum level of endothelin1 (as an inflammatory index) [11]. 
Boskabady et al. reported that saffron had a potent relaxant effect on tracheal chains 
of guinea pigs which was comparable to or even higher than that of theophylline [7].
3. Magnesium and asthma
Insufficient magnesium (Mg) intake can influence the management of asthma 
[12, 13]. Some drugs used in the treatment of asthma reduce the body’s magnesium 
storage [14]. For example, β2-receptor agonist drugs can increase urinary excretion 
of magnesium and thus lead to magnesium deficiency [15].
Magnesium has muscle relaxant effects and bronchodilator effects [16] because 
of physiologic calcium antagonist effects [17] or adenylyl cyclase activation action 
[18]. Results of a clinical trial on 112 patients with mild to moderate asthma sug-
gested that 340 mg MgSO4 supplementation for 2 months had bronchodilation 
effects and improved the lung function and so can be used as an emergency treat-
ment for asthma attack [19].
Alexandra et al. [20] surveyed the effect of magnesium in patients with mild to 
moderate asthma. They showed that 340 mg Mg supplementation for 6.5 months 
significantly increased the concentration of methacholine required to cause 20% 
drop in the forced expiratory volume in 1 minute (FEV1) and improved the peak 
expiratory flow rate (PEFR). Mg also improved the quality of life and asthma 
control in comparison to control group [20].
For children with moderate-to-severe asthma, magnesium seems to be benefi-
cial. It is a safe drug to prescribe but has minor side effects reported, for example, 
pain and numbness at the infusion site, hypotension, epigastric or facial warmth, 
flushing, dry mouth, and malaise. Due to the anti-inflammatory and bronchodi-
lating effects, magnesium can be considered as an adjuvant therapy in pediatric 
patients who do not respond to conventional treatment in severe manifestations of 
asthma. Future studies should investigate the best route of administration and the 
optimal dosage for most benefits [21].
Because of the difficulties in measurement and also interpretation of extracel-
lular vs. intracellular forms of magnesium, the relationship between asthma and 
magnesium deficiency is unclear [15]. Some studies reported that low dietary mag-
nesium intake (which is the major determinant in homeostasis of magnesium) may 
be involved in the etiology of chronic obstructive airway disease and asthma [15]. 
Britton et al. reported that 100 mg/d higher dietary magnesium intake was indepen-
dently associated with higher FEV1 and lower bronchial hyperreactivity [22].
4. Curcumin and asthma
Curcumin is the yellow pigment of turmeric (Curcuma longa) (a spice) which 
has anti-inflammatory [23] and anti-allergic [24] and antiasthmatic [24] effects. 
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In a murine model of chronic asthma, it is reported that curcumin similar to dexa-
methasone improved histological changes of chronic asthma [23]. Subhashini et al. 
reported that curcumin via intranasal rout in asthmatic mice suppressed airway 
inflammation [24]. So, curcumin as a complementary drug in the nasal drop form 
(without systemic side effects) for local use can be produced.
Chauhan et al. [25] reported that in murines with chronic asthma, curcumin 
(without any side effects) reduced airway inflammation and remodeling. It 
decreased IgE, TNF-α, and Th2 responses and increased Th1 route (as a protective 
response) [25].
In a clinical trial, curcumin supplementation (1000 mg twice a day) in atopic 
asthmatic patients has no significant effect on FEV1, serum immunoglobulin E, dose 
of bronchodilator consumption, and asthma control in comparison to placebo [26].
Some anti-inflammatory mechanisms of curcumin include regulation of nuclear 
factor kB (NF-kB) (as a transcription factor), cytokines (TNF-α and IL-6), and 
adenosine molecules (ICAM-1) [27].
5. Macro- and micronutrients and other nutritional factors and asthma
Oxidative stress has an important role in the progress of asthma. There are some 
potent evidences that the oxidant-to-antioxidant ratio reduces in asthmatic patients. 
Oxygen and nitrogen active species have primary effect on the airway inflammation 
and are indicators of asthma severity [28]. So, supplementation of antioxidants in 
asthma has some beneficial effects on the progression and severity of disease. It 
seems that a diet rich in monounsaturated fats and antioxidants that counteract the 
oxidative stress has a protective effect in children with asthma [29].
It is suggested that antioxidant supplementation can modulate the effects of 
airway injury in asthmatic patients who are exposed to air pollutants such as ozone. 
A clinical trial in Mexico City showed that supplementation of vitamins C and E in 
children with moderate-to-severe asthma reduced the loss of airway function [30].
Studies have also associated selenium deficiency with asthma [31]. A reverse 
relationship was seen between wheezing symptoms and insufficient vitamin E 
intake, but the association between asthma and vitamin E was not seen. Thus more 
studies must be done to understand the mechanism of vitamin E in the oxidation 
and inflammation of asthmatic patients [32, 33]. Nuts contain selenium and vitamin 
E and thus are a good choice for asthmatic patients [34].
It is reported that there is an association between asthma and low serum levels of 
carotenoids. Supplementation of omega-3 polyunsaturated fatty acids of fish oil in 
asthmatic children decreased the wheezing, but into later childhood this beneficial 
effect did not continue. It is reported that supplementation of zinc and vitamin C 
also improves the lung function and asthma symptoms [29].
Conflicting results on the benefits of vitamin D supplementation have been 
reported. In one study low serum levels (less than 30 ng/dL) of vitamin D were 
related to an increase in exacerbation of asthma [35]. In another study, high doses of 
vitamin D supplementation were not associated with any protective effect [36].
Children with a higher than desirable body mass index (BMI) have a significant 
increase in the risk of development of asthma. In obese children with asthma, 
weight loss diets showed improvements in the lung function, control of asthma, 
and quality of life [37]. The effectiveness of inhaled corticosteroid drugs is low in 
overweight and obese asthmatic patients [38].
The nutritionists should train the overweight and obese patients about the role 
of weight management in asthma control, discuss about suitable energy intake and 
activity, and review the known food allergies. Also the nutritionist should provide 
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high-quality protein, vitamins, and minerals in the form of small meals to reduce 
the risk of infection [34].
Exposure to food allergens, especially an immunoglobulin E-mediated reac-
tion to a food protein, can cause bronchoconstriction. Complete removal of the 
allergenic food protein is the only dietary advice which is currently available for 
food allergies. Some sulfites, such as sodium and potassium sulfides (in processed 
foods), have been found to be a trigger for patients with asthma [39]. Some com-
mon food allergens for children include eggs, milk, seafood, peanuts, tree nuts, fish, 
soy, or wheat and for adults include peanuts, tree nuts, shellfish, and fish [34].
Percentage of energy intake from fat in asthmatic patients must be high, because 
the respiratory quotient (RQ ) of fats is lower than carbohydrate and protein [33].
Prostanoid production may be affected by dietary fat composition. 
Observational studies (from the 1960s and 1970s) reported that in population 
whose diets were rich in fish oil, the incidence of asthma was low [40]. Some 
studies demonstrated the fish oil anti-inflammatory effects (reduced leukocyte 
chemotaxis and leukotriene production) in asthmatic patients [41], but results 
of a systematic review showed that there is no consistent effect of fish oil on 
lung function, asthma medication use, bronchial hyperreactivity, and asthma 
symptoms [40]. A review covering 26 studies (randomized, placebo-controlled, 
and others) reported that the effect of w-3 fatty acid supplements could not be 
conclusive [42].
When the immune system of infants is immature, breastfeeding protects the 
immunological system and in early childhood provides a modest protective effect 
from wheeze [43, 44]. If the duration of breastfeeding could be longer, the protec-
tive effects seem to be more. Supplementation the diet of lactating women with fish 
oil could be related with alteration in the immune response of neonates to allergens, 
and insufficient intake of zinc and vitamins D and E during pregnancy is related to 
increased wheezing and asthma in children up to age of 5 years old [45]. Maternal 
intake of vitamins E and D can modify the development of the lung of neonates 
[45]. It is reported that insufficient serum level of vitamin D is an index for severity 
of asthma in childhood [46].
Theobromine in cocoa leads to increase blood flow to the brain and so reduces 
coughing and is a good food choice for asthmatic patients. It is better that these 
patients consume less sodium in their diet. In 5–20% of asthmatics patients who 
are sensitive to aspirin, salicylate sensitivity is common. Some vegetables and many 
fruits contain salicylates. Quercetin in pears, apples, onions, berries, and oranges 
should be encouraged in an amount of five or more servings per week [34].
6. Botanicals, herbs, and supplements
• ASHMI, a combination of three herbal extracts (Ganoderma lucidum (fungal), 
Sophora flavescens, and Glycyrrhiza uralensis (Fabaceae species)), is used in 
China for antiasthma intervention [47], and in oriental cultures and Vietnam, 
the seaweed is used [48].
• Gamma linolenic acid (GLA; borage oil) as a dietary fatty acid without any side 
effects can modulate the endogenous inflammatory mediators [49].
• Ephedra has bronchodilator effects, but it has some side effects such as signifi-
cantly increasing blood pressure and heart rate, arrhythmias, and problems 
with blood glucose. This has been removed from the market by the Food and 
Drug Administration (FDA), but some forms are available.
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• Licorice, stinging nettle, gingko, and anise have not shown efficacy, and side 
effects of these should be evaluated [34].
• Boswellia serrata extract has anti-inflammatory effects due to the triterpene 
compounds [50]. The mechanism of anti-inflammatory properties of boswellic 
acids is inhibition of proteases (cathepsin G), lipoxygenases (enzyme which is 
responsible for the synthesis of leukotrienes), and NF-kB [51].
7. Probiotics and asthma
It is reported that the intestinal flora can affect the mucosal immunity and so 
may be an effective factor for allergic disease [52]. Exposure to microbial flora in 
early childhood can lead to a change in the Th1/Th2 ratio toward the Th1 response.
Some studies suggested that the content of intestinal flora can be different 
in patients with allergic disease and also in individuals who live in industrialized 
countries (where the prevalence of allergic disease is higher) [53–55]; patients with 
allergic disease have less Bifidobacteria and Lactobacilli and more Clostridia and 
Staphylococcus aureu [56, 57].
The World Allergy Organization in 2015 recommended the use of probiotics for 
prevention of allergy in:
a. Pregnant women who have children with high risk of allergy
b. Mothers lactating infants with high risk of developing allergy
c. Infants who have risk of progressing allergies [58]
Results of a meta-analysis demonstrated that there is no evidence for protective 
effect of perinatal probiotic administration and childhood wheeze or asthma. So 
there is insufficient evidence for supplementation of probiotics for the preven-
tion of allergic disorders and asthma, and more studies are required to explore the 
potential relationship between probiotic and asthma [59].
Generally, probiotic consumption for prevention of asthma and allergy is based 
on the little evidences, and more studies are needed for exact evaluation of the role 
of microflora in allergic disease and for determination of the best type of probiotic 
for supplementation in allergic disease [60].
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